The study demonstrates efficient asymmetric synthesis in butadiene reactions, highlighting the role of palladium catalysis and chiral aldehydes.
Butadiene is one of the most important chemical feedstocks used for the construction of value-added molecules. However, much of the existing endeavors have primarily focused on the achiral synthesis. Alternatively, although the aryl radical-involved transformations have been extensively disclosed, the corresponding catalytic asymmetric methodologies remain exceedingly rare. In this study, we present a highly efficient three-component asymmetric 1,4-arylalkylation of butadiene utilizing readily available aryl bromides and NH2-unprotected amino acid esters. This process is facilitated by photoinduced chiral aldehyde/palladium combined catalysis. A diverse array of chiral nonproteinogenic α,α-disubstituted α-amino acid esters with unique structures is generated with 35–81% yields and 71–98% ee values. The resulting products can be easily converted to other structurally diverse α-amino acids. Density functional theory (DFT) calculations indicate that the final enantioselectivity is governed by a synergistic reaction model that encompasses noncovalent interactions between Pd···Br···Zn as well as strong C–H···Br and π···π dispersion interactions.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: